sur New To The Street
New to The Street and NRx Pharmaceuticals Launch 12-Part Media Series
New to The Street, a prominent multi-platform financial news show, announced a 12-part media partnership with NRx Pharmaceuticals, Inc., a biopharmaceutical firm focused on life-saving therapies for severe mental health conditions. This collaboration will include monthly televised interviews with NRx CEO Dr. Jonathan Javitt, sharing updates on biotech innovations.
The partnership will extend across television, digital media, and outdoor platforms. It plans to produce content for networks like ABC, NBC, and CBS, alongside TV commercials and billboards in high-traffic areas such as Times Square.
The series will commence later this month on Fox Business and Bloomberg Television, aiming to reach over 245 million homes across the U.S. and the Middle East. Additionally, episodes will be available on New to The Street's YouTube channel, supported by extensive media amplification.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de New To The Street